Laura Wood on Multidisciplinary Collaboration for Managing Immunotherapy Adverse Events
By Laura Wood, RN, MSN, OCN
PUBLISHED THURSDAY, JANUARY 1, 1970
Laura Wood, RN, MSN, OCN, Cleveland Clinic explains the importance of a multidisciplinary approach when treating patients on immunotherapy.
Patients receiving immunotherapy treatments have autoimmune-type adverse events that are unlike those of chemotherapy. The side effects can be prolonged and require careful monitoring as well as multidisciplinary collaboration. Checking in with gastrointestinal, endocrinology, and other specialists can help to manage and monitor these side effects.
You must log in to use this feature, please click here to login.